Leadership in Business Technology Innovation Recognized
ME Newswire / Business Wire
RESEARCH TRIANGLE PARK, N.C - Monday, September 9th 2013
Quintiles has been recognized for its leadership in business technology innovation with its inclusion in the InformationWeek 500 for the fifth consecutive year.
Quintiles created an industry-wide platform, Infosario Safety, which addresses the challenges of managing drug safety to improve patient outcomes and drive compliance with changing regulatory requirements while enhancing quality and productivity across a product’s lifecycle.
“A cloud-based solution fully integrated with regulatory agencies around the world, Infosario Safety simplifies processes and eliminates the fragmented technology and vendor complexities associated with running an efficient, high-quality pharmacovigilence operation at any drug company,” said Quintiles Chief Information Officer Richard Thomas.
“Creating something new and of high value is never easy. This innovation accolade puts a spotlight on the team of Quintiles professionals who came together and envisaged an industry solution to a complex series of challenges – testament to them that they then went on to deliver it,” Thomas added.
Over the past five years, InformationWeek has recognized Quintiles for numerous industry leading business technology innovations across the drug development continuum. These innovations are key components of Quintiles Infosario, an end-to-end, cloud-based platform for drug development. Built on industry standards and in close collaboration with some of the world’s leading organizations in the pharmaceutical industry, Quintiles Infosario eliminates IT complexities and empowers researchers to focus on making data-driven decisions at every step of the way.
InformationWeek identifies and honors the nation's most innovative users of information technology with its annual InformationWeek 500 listing, and also tracks the technology, strategies, investments and administrative practices of some of the best‐known organizations in the country.
"The theme of this year's InformationWeek 500 is digital business. It's a movement rooted in data analytics, mobile computing, social networking and other customer‐focused technologies that are turning companies and industries on their ear," said InformationWeek Editor In Chief Rob Preston. "Every enterprise is now a digital business — or needs to become one fast. The companies in our ranking are leading the way."
Unique among corporate rankings, the InformationWeek 500 spotlights the power of innovation in information technology. The full list can be found at www.informationweek.com/500
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Media Relations:
Phil Bridges, + 1-919-998-1653
Mobile: +1-919-457-6347
phil.bridges@quintiles.com
Investor Relations:
Karl Deonanan, +1-919-998-2789
InvestorRelations@quintiles.com
Permalink: http://www.me-newswire.net/news/8458/en
ME Newswire / Business Wire
RESEARCH TRIANGLE PARK, N.C - Monday, September 9th 2013
Quintiles has been recognized for its leadership in business technology innovation with its inclusion in the InformationWeek 500 for the fifth consecutive year.
Quintiles created an industry-wide platform, Infosario Safety, which addresses the challenges of managing drug safety to improve patient outcomes and drive compliance with changing regulatory requirements while enhancing quality and productivity across a product’s lifecycle.
“A cloud-based solution fully integrated with regulatory agencies around the world, Infosario Safety simplifies processes and eliminates the fragmented technology and vendor complexities associated with running an efficient, high-quality pharmacovigilence operation at any drug company,” said Quintiles Chief Information Officer Richard Thomas.
“Creating something new and of high value is never easy. This innovation accolade puts a spotlight on the team of Quintiles professionals who came together and envisaged an industry solution to a complex series of challenges – testament to them that they then went on to deliver it,” Thomas added.
Over the past five years, InformationWeek has recognized Quintiles for numerous industry leading business technology innovations across the drug development continuum. These innovations are key components of Quintiles Infosario, an end-to-end, cloud-based platform for drug development. Built on industry standards and in close collaboration with some of the world’s leading organizations in the pharmaceutical industry, Quintiles Infosario eliminates IT complexities and empowers researchers to focus on making data-driven decisions at every step of the way.
InformationWeek identifies and honors the nation's most innovative users of information technology with its annual InformationWeek 500 listing, and also tracks the technology, strategies, investments and administrative practices of some of the best‐known organizations in the country.
"The theme of this year's InformationWeek 500 is digital business. It's a movement rooted in data analytics, mobile computing, social networking and other customer‐focused technologies that are turning companies and industries on their ear," said InformationWeek Editor In Chief Rob Preston. "Every enterprise is now a digital business — or needs to become one fast. The companies in our ranking are leading the way."
Unique among corporate rankings, the InformationWeek 500 spotlights the power of innovation in information technology. The full list can be found at www.informationweek.com/500
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Media Relations:
Phil Bridges, + 1-919-998-1653
Mobile: +1-919-457-6347
phil.bridges@quintiles.com
Investor Relations:
Karl Deonanan, +1-919-998-2789
InvestorRelations@quintiles.com
Permalink: http://www.me-newswire.net/news/8458/en